Abstract
Cisplatin (DDP) is a potent chemotherapeutic drug, which can regulate tumor cell apoptosis by up-regulating caspase-3 activity. Thus, monitoring caspase-3 activity in breast cancer cells can directly illustrate the efficiency of DDP treatment. In this study, by using reduced graphene oxide (rGO) as a quencher of a fluorescence labeled peptide, we developed an “off to on” method to monitor the effect of DDP on caspase-3 in breast cancer cells. In this method, the rGO quenched fluorescence with an ultra-high level of efficiency. Caspase-3 hydrolyzed the polypeptide probe, generating two segments of different lengths. The release of a short segment marked with fluorophores led to the recovery of the fluorescence signal (Ex/Em = 450/521 nm). Under the optimal conditions, the linear range of caspase-3 was 0.4–7 U mL−1 and the limit of detection was 0.33 U mL−1. The upregulating effect of DDP on intracellular caspase-3 activity was visualized with the “off to on” method and flow cytometry assay showed that caspase-3 activity increased along with the apoptosis rate of tumor cells. The above results show the practical application of the method for evaluating the efficacy of drugs against cancer cells.
Funding Information
  • National Natural Science Foundation of China (82003931)
  • Key Research and Development Project of Hainan Province (ZDYF2022SHFS075)
  • Natural Science Foundation of Hunan Province (2023JJ30096, 2023JJ40130)

This publication has 31 references indexed in Scilit: